Document Detail

Plasma Fatty Acids in Premature Infants With Hyperbilirubinemia: Before-and-After Nutrition Support With Fish Oil Emulsion.
MedLine Citation:
PMID:  23319354     Owner:  NLM     Status:  In-Data-Review    
Infants who are dependent on parenteral nutrition (PN) sometimes develop PN-associated cholestasis (PNAC). A compassionate use protocol, approved by the U.S. Food and Drug Administration and the institutional review board, guided enrollment of hospitalized infants with PNAC (<1 year of age, PN dependence for >3 weeks). Plasma concentrations of essential fatty acids were monitored before and after a soybean-based PN lipid, infused at 3 g/kg body weight/d, was replaced by an experimental fish oil-based intravenous fat emulsion (FO-IVFE) at 1.0 g/kg/d. All participants were born premature (n = 10; 20% male). At enrollment, infants were (mean ± SD) 86.5 ± 53.5 days of life and weighed 2.24 ± 0.87 kg; direct bilirubin was 5.5 ± 1.3 mg/dL. After treatment, blood concentrations significantly increased from baseline (P < .017) for circulating eicosapentaenoic acid (6.3 ± 3.0 to 147.8 ± 53.1 µg/mL), docosahexaenoic acid (20.7 ± 6.5 to 163.7 ± 43.4 µg/mL), pristanic acid (0.01 ± 0.01 to 0.17 ± 0.03 µg/mL), and phytanic acid (0.06 ± 0.03 to 0.64 ± 0.15 µg/mL). In contrast, total plasma ω-6 fatty acids (including linoleic acid) decreased (P < .017). The triene/tetraene ratio remained below the threshold value of 0.2 that defines ω-6 deficiency. No adverse effects were observed attributable to FO-IVFE. Discontinuation of FO-IVFE was typically due to infants (body weight 3.76 ± 1.68 kg) transitioning to enteral feeding rather than for resolution of hyperbilirubinemia (direct bilirubin 7.9 ± 4.8 mg/dL). These exploratory results suggest that FO-IVFE raises circulating ω-3 fatty acids in premature infants without development of ω-6 deficiency in the 8.3 ± 5.8-week time frame of this study.
Catherine J Klein; Thomas G Havranek; Mary E Revenis; Zahra Hassanali; Louis M Scavo
Related Documents :
17253864 - Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory act...
24310974 - Interactions between parallel pathways during biosynthesis of rosmarinic acid in cell s...
24889904 - Highly effective copper-mediated gem-difluoromethylenation of arylboronic acids.
2808134 - Isolation and characterization of thioxamycin.
10069984 - Cloning and characterization of a human electrogenic na+-hco-3 cotransporter isoform (h...
4729974 - Fat absorption in essential fatty acid deficiency: a model experimental approach to stu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition     Volume:  28     ISSN:  1941-2452     ISO Abbreviation:  Nutr Clin Pract     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8606733     Medline TA:  Nutr Clin Pract     Country:  United States    
Other Details:
Languages:  eng     Pagination:  87-94     Citation Subset:  IM; N    
Catherine J. Klein, Childrens National Medical Center, 111 Michigan Ave, Washington, DC 20010, USA. Email:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nutrition assessment and management in advanced liver disease.
Next Document:  Readiness for Change Predicts VA Mental Healthcare Utilization Among Iraq and Afghanistan War Vetera...